Search research articles
Contact Us
Filters
Showing results (91-100 of 308) with videos related to
Page
of 31
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
July 10, 2009
Processing of two latent membrane protein 1 MHC class I epitopes requires tripeptidyl peptidase II involvement
Jan Diekmann, Eleni Adamopoulou, Olaf Beck, et al.
Gene Therapy
|
March 19, 2010
Feline leukemia virus integrase and capsid packaging functions do not change the insertion profile of standard Moloney retroviral vectors
J-Y Métais, S Topp, R T Doty, et al.
Blood
|
May 10, 2018
Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab
Max S Topp, Zachary Zimmerman, Paul Cannell, et al.
Annals of Hematology
|
October 4, 2016
Epileptic seizures and rhinocerebral mucormycosis during blinatumomab treatment in a patient with biphenotypic acute leukemia
Niklas Vogt, Katharina Heß, Ralf Bialek, et al.
Bone Marrow Transplantation
|
June 26, 2010
Auto-SCT in severe paraproteinemic neuropathy
H D Hummel, J C Rath, H Wiendl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 1, 1995
Recombinant human stem cell factor does exert minor stimulation of growth in small cell lung cancer and melanoma cell lines
C A Papadimitriou, M S Topp, H Serve, et al.
Blood
|
November 1, 1993
Recombinant human interleukin-4 inhibits growth of some human lung tumor cell lines in vitro and in vivo
M S Topp, M Koenigsmann, A Mire-Sluis, et al.
Leukemia
|
January 26, 2017
Frequency of regulatory T cells determines the outcome of the T-cell-engaging antibody blinatumomab in patients with B-precursor ALL
J Duell, M Dittrich, T Bedke, et al.
Cancer Medicine
|
March 18, 2021
Blinatumomab as first salvage versus second or later salvage in adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemia: Results of a pooled analysis
Max S Topp, Anthony S Stein, Nicola Gökbuget, et al.
Leukemia & Lymphoma
|
October 1, 1995
Antiproliferative effect of human interleukin-4 in human cancer cell lines: studies on the mechanism
M S Topp, C A Papadimitriou, F Eitelbach, et al.
Page
of 31
Search research articles
Search
Showing results (91-100 of 308) with videos related to
Sort By:
Page
of 31
Journal of Immunology (Baltimore, Md. : 1950)
|
July 10, 2009
Processing of two latent membrane protein 1 MHC class I epitopes requires tripeptidyl peptidase II involvement
Jan Diekmann, Eleni Adamopoulou, Olaf Beck, et al.
Gene Therapy
|
March 19, 2010
Feline leukemia virus integrase and capsid packaging functions do not change the insertion profile of standard Moloney retroviral vectors
J-Y Métais, S Topp, R T Doty, et al.
Blood
|
May 10, 2018
Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab
Max S Topp, Zachary Zimmerman, Paul Cannell, et al.
Annals of Hematology
|
October 4, 2016
Epileptic seizures and rhinocerebral mucormycosis during blinatumomab treatment in a patient with biphenotypic acute leukemia
Niklas Vogt, Katharina Heß, Ralf Bialek, et al.
Bone Marrow Transplantation
|
June 26, 2010
Auto-SCT in severe paraproteinemic neuropathy
H D Hummel, J C Rath, H Wiendl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 1, 1995
Recombinant human stem cell factor does exert minor stimulation of growth in small cell lung cancer and melanoma cell lines
C A Papadimitriou, M S Topp, H Serve, et al.
Blood
|
November 1, 1993
Recombinant human interleukin-4 inhibits growth of some human lung tumor cell lines in vitro and in vivo
M S Topp, M Koenigsmann, A Mire-Sluis, et al.
Leukemia
|
January 26, 2017
Frequency of regulatory T cells determines the outcome of the T-cell-engaging antibody blinatumomab in patients with B-precursor ALL
J Duell, M Dittrich, T Bedke, et al.
Cancer Medicine
|
March 18, 2021
Blinatumomab as first salvage versus second or later salvage in adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemia: Results of a pooled analysis
Max S Topp, Anthony S Stein, Nicola Gökbuget, et al.
Leukemia & Lymphoma
|
October 1, 1995
Antiproliferative effect of human interleukin-4 in human cancer cell lines: studies on the mechanism
M S Topp, C A Papadimitriou, F Eitelbach, et al.
Page
of 31